781253004: Netarsudil (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Rho-associated protein kinase inhibitor\Netarsudil (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amino acid\Netarsudil (substance)

\Organic compound\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic acid\Amino acid\Netarsudil (substance)
\Organic compound\Organic nitrogen compound\Amino acid\Netarsudil (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3745656016 Netarsudil (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3745657013 Netarsudil en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Netarsudil (substance)	Is a	Amino acid	true	Inferred relationship	Some
Netarsudil (substance)	Is a	Rho-associated protein kinase inhibitor	true	Inferred relationship	Some
Netarsudil (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Rho-associated protein kinase inhibitor	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Netarsudil only product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Netarsudil (substance)	Inferred relationship	Some	1
Netarsudil-containing product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Netarsudil (substance)	Inferred relationship	Some	1
Product containing netarsudil (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Netarsudil (substance)	Inferred relationship	Some	1
Product containing only netarsudil (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Netarsudil (substance)	Inferred relationship	Some	1
Product containing latanoprost and netarsudil (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Netarsudil (substance)	Inferred relationship	Some	2
Product containing only latanoprost and netarsudil (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Netarsudil (substance)	Inferred relationship	Some	2
Product containing latanoprost and netarsudil in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Netarsudil (substance)	Inferred relationship	Some	2
Latanoprost and netarsudil only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Netarsudil (substance)	Inferred relationship	Some	2
Product containing precisely netarsudil 200 microgram/1 milliliter conventional release solution for eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Netarsudil (substance)	Inferred relationship	Some	1
Product containing precisely netarsudil 200 microgram/1 milliliter conventional release solution for eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Netarsudil (substance)	Inferred relationship	Some	1

This concept is not in any reference sets